CMPS News and Press, COMPASS Pathways Plc From 09/19/23

(NewsDirect) By Faith Ashmore, Benzinga Treatment-resistant depression, also referred to as TRD, is a subset of depression that poses significant challenges for clinicians, patients and those closest to patients. It is characterized by persistent symptoms of depression that do not respond...

2023-09-19 08:00:18 ET FN Media Group Presents GlobalInvestmentDaily.com Market Commentary London – September 19, 2023 – Depression is costing the economy $1 trillion in lost production every single year. Yet, a classical compound that even the FDA has twi...

LONDON, Sept. 18, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the appointment of Daphne Karydas to its Board of Directors, ef...

2023-09-16 16:00:56 ET On Sept. 14, the Multidisciplinary Association for Psychedelic Studies ("MAPS") announced positive results on a second phase 3 trial for MDMA -- also known as ecstasy -- for post-traumatic stress disorder that were published in a scientific journal. The data in th...

Michigan lawmakers want the U.S. Congress, the Department of Veteran Affairs (VA) and the Department of Defense (DOD) to make psychedelic research a priority . Policymakers are calling on Congress to prioritize investment in the research of “nontechnology treatment options” such as...

--News Direct-- By Rachael Green, Benzinga In August, a group of well-known biotech institutional investors participated in an up to almost $300 million financing round for COMPASS Pathways (NASDAQ: CMPS), consisting of an initial investment of $125 million and the potential for an ad...

2023-09-11 06:41:42 ET COMPASS Pathways ( NASDAQ: CMPS ) on Friday filed a prospectus related to the proposed resale of 40.09M ADS by the selling securityholders. This prospectus is not an offer to sell these securities. S-3 For further details see: COMPASS P...

Colorado officials will hold online hearings to gather public opinions on Colorado’s efforts to implement psychedelic decriminalization measures. The state became one of the first regions in the country to pass psychedelic policy after Colorado voters approved a measure to decriminaliz...

LONDON, Sept. 06, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the publication of a new paper in Pyschopharmacology, which...

A retired firefighter from California is funding psychedelic retreats for firefighters to help address mental disorders they developed while on the job. Access to psychedelics in the United States is mostly limited to a small number of clinical studies, meaning that the... Read more »...